FDA warns against misuse of laxatives

FDA warns against misuse of laxatives
Ignoring dosing instructions, cautions can lead to serious side effects with some of these products.

(HealthDay)—If you are constipated and need to use a laxative, the U.S. Food and Drug Administration wants you to know that some products can be dangerous if you don't follow the dosing instructions or you have certain medical conditions.

The agency said there have been dozens of reports of serious , including 13 deaths, among people taking sodium phosphate laxatives, which are sold over-the-counter.

Laxatives with sodium phosphates are marketed under the brand name "Fleet" and also as store brands and generic products. All of them can cause serious side effects if used improperly. These side effects include dehydration or abnormal levels of electrolytes in the blood that can lead to complications such as kidney damage and death.

The labels on these products state that they should be used as a single dose taken once a day, should not be used for more than three days, and that patients who are dehydrated or have or heart problems should consult a professional before taking these laxatives.

The FDA also said that adults older than 55 and children with certain health conditions should talk to a health care professional before using sodium phosphate laxatives because they may be at increased risk for harmful side effects.

The new warnings, which are not currently included on the label on these laxatives, apply to adults and children with inflammation of the colon and those taking certain drugs, including: medicines that affect how the kidneys work, such as diuretics or fluid medicines; such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs); heart or kidney failure medications; and nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.

"The bottom line is that these products are safe for otherwise healthy adults and older children . . . as long as they follow these dosing instructions and don't take the product more often, or in greater amounts, than the label instructs," Dr. Mona Khurana, a medical officer in FDA's division of nonprescription regulation development, said in an agency news release.

In recent reviews, the FDA has identified 54 cases of serious side effects associated with the oral or rectal use of sodium phosphate laxatives in adults and children. Twelve adults and one child died.

More information: The American Academy of Family Physicians has more about laxatives.

add to favorites email to friend print save as pdf

Related Stories

FDA warns pregnant women about migraine drugs

May 06, 2013

(HealthDay)—Pregnant women who struggle with migraine headaches should never use medicines containing the ingredient valproate because they can lower the IQ scores of their children, the U.S. Food and Drug ...

FDA warns of rare skin reactions to acetaminophen

Aug 02, 2013

(HealthDay)—The widely used painkiller acetaminophen, best known as Tylenol, can cause rare but serious skin reactions and a warning about this danger will be added to product labels, the U.S. Food and ...

Doubling up on cold, flu remedies may harm liver

Jan 30, 2013

(HealthDay)—Taking too much acetaminophen, an active ingredient in many commonly used drugs for fever and pain relief, including Tylenol, can cause liver damage, experts at the U.S. Food and Drug Administration ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments